pubmed-article:19704173 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0010825 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0029216 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0524930 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0440790 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0017066 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0909381 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:19704173 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:19704173 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19704173 | pubmed:dateCreated | 2009-8-25 | lld:pubmed |
pubmed-article:19704173 | pubmed:abstractText | The rate of cytomegalovirus (CMV) mutations conferring ganciclovir resistance was assessed in a trial comparing intravenous ganciclovir and oral valganciclovir for treatment of CMV disease in solid organ transplant (SOT) recipients. | lld:pubmed |
pubmed-article:19704173 | pubmed:language | eng | lld:pubmed |
pubmed-article:19704173 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19704173 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19704173 | pubmed:issn | 1359-6535 | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:HumarAtulA | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:AsbergAndersA | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:JardineAlan... | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:BoivinGuyG | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:GoyetteNathal... | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:PescovitzMark... | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:HartmannAnder... | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:IvesJaneJ | lld:pubmed |
pubmed-article:19704173 | pubmed:author | pubmed-author:RollagHalvorH | lld:pubmed |
pubmed-article:19704173 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19704173 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:19704173 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19704173 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19704173 | pubmed:pagination | 697-704 | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:meshHeading | pubmed-meshheading:19704173... | lld:pubmed |
pubmed-article:19704173 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19704173 | pubmed:articleTitle | Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. | lld:pubmed |
pubmed-article:19704173 | pubmed:affiliation | Infectious Disease Research Center of the Centre hospitalier universitaire de Québec, Québec City, QC, Canada. Guy.Boivin@crchul.ulaval.ca | lld:pubmed |
pubmed-article:19704173 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19704173 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19704173 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |